Methanolysis / Circular Platform Momentum
Renewed methanolysis platform driving revenue growth in specialty plastics and rPET with new wins in Tritan and cosmetic packaging; company reiterates prior guidance of ~4%–5% revenue growth and notes potential upside as rPET demand strengthens versus rising virgin PET prices.
Chemical Intermediates Tightness Driving Margin Improvement
Tighter global supply (Middle East disruption) has increased spreads and demand for CI volumes; company expects Chemical Intermediates EBIT of roughly $50 million in Q2 with continued sequential strength and meaningful upside from expanded spreads and additional volume to sell versus last year.
Large Pricing Actions Implemented
Management has initiated approximately $500 million of price increases across the portfolio; specialties are pacing mid-single-digit sequential price increases (Q1→Q2) while Chemical Intermediates pricing is ramping in the high-teens (approaching ~20% sequential).
IEEPA Tariff Refund and Winter Storm Impact Net Neutral in Q1
Company recognized about $20 million of IEEPA tariff refunds in Q1 which largely neutralized the winter storm operational impact, resulting in Q1 results that were broadly in line with January guidance (refund cash to be received in H2).
Strong Commercial Wins and Supply-Security Advantage
North American vertical integration and lower energy cost base vs Asian competitors is yielding commercial wins, potential market-share gains, and customer interest in longer-term contracts; management expects the security-of-supply value proposition to drive durable customer relationships.
Positive Cash Flow and EPS Outlook
Management expects improved full-year earnings and stated adjusted earnings-per-share should be above $6, with operating cash generation approaching last year's levels and Q1 cash consumption lower year-over-year.